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Abstract
Metastasis suppressor genes (MSGs) inhibit different biological processes during metastatic progression without globally influencing
development of the primary tumor. The firstMSG, NM23 (non-metastatic clone 23, isoformH1) or now called NME1 (stands for non-
metastatic) was identified some decades ago. Since then, ten humanNM23 paralogs forming two groups have been discovered. Group
INM23 genes encode enzymeswith evolutionarily highly conserved nucleoside diphosphate kinase (NDPK) activity. In this reviewwe
summarize how results fromNDPKs inmodel organisms converged on humanNM23 studies. Next, we examine the role of NM23-H1
and its homologs within the metastatic cascade, e.g. cell migration and invasion, proliferation and apoptosis. NM23-H1 homologs are
well known inhibitors of cell migration.Drosophila studies revealed that AWD, the fly counterpart of NM23-H1 is a negative regulator
of cell motility by modulating endocytosis of chemotactic receptors on the surface of migrating cells in cooperation with Shibire/
Dynamin; this mechanism has been recently confirmed by human studies. NM23-H1 inhibits proliferation of tumor cells by phos-
phorylating the MAPK scaffold, kinase suppressor of Ras (KSR), resulting in suppression of MAPK signalling. This mechanism was
also observed with the C. elegans homolog, NDK-1, albeit with an inverse effect on MAPK activation. Both NM23-H1 and NDK-1
promote apoptotic cell death. In addition, NDK-1, NM23-H1 and their mouse counterpart NM23-M1 were shown to promote
phagocytosis in an evolutionarily conserved manner. In summary, inhibition of cell migration and proliferation, alongside actions in
apoptosis and phagocytosis are all mechanisms through which NM23-H1 acts against metastatic progression.
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Introduction: NM23-H1, the First Metastasis
Suppressor
In the nineteen sixties, oxidative phosphorylation and histidine
phosphorylation were competing theories in cellular energy
synthesis. The latter process involves the lability of the phos-
phorylated nitrogens on histidine which creates a high energy
phospho-intermediate that drives cellular thermodynamics. This
review centres on a family of NM23/NDPK enzymes (n-
ucleoside diphosphate kinases, see below) that synthesise such
high energy phospho-histidines using trinucleotides such as
ATP as donors. They are found within multiple cellular path-
ways and first considered as housekeeper enzymes. The gene
encoding the first NM23/NDPK member was identified as a
metastasis suppressor gene (MSG) inhibiting one or more steps
of the mechanism whereby cancer cells gradually acquire inde-
pendence from the primary tumor. These ordered sequential
steps are called the metastatic cascade and the underlying genes
differ from mutations globally affecting the initial growth of the
primary tumor. The number of human metastasis suppressor
genes is now numbered at about 30 [1, 2] but the first to be
discovered was NM23-H1 (non-metastatic clone 23, isoform
H1) now renamedNME1 (non-metastatic).NM23-H1was iden-
tified in 1988 by comparing a non-metastatic mouse melanoma
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cell line against its highly metastatic counterpart [3].
Specifically, the mouse isoform NM23-M1 was downregulated
in the metastatic variant [3] and later experiments on various
NM23 homologs showed reduced expression in metastatic can-
cer cells compared to their non-metastatic counterparts. This is a
common feature ofMSGs [1, 2]. The exact mechanismwhereby
NM23-H1 expression is lost in invasive tumors still remains to
be elucidated. However, several mechanisms were proposed in
this context, such as direct cleavage by lysosomal cathepsins [4],
downregulation of NM23 expression through chromatin remod-
elling [5] or methylation of CpG islands on its promoter [6],
ubiquitination leading to protein degradation [7] or silencing
by miRNA [8].
Further complexity then arose because the human genome
not only encodes ten NM23 (or NME) homologs, - divided into
two groups based on sequence homology and enzymatic activity
-, but many gene products share overlapping functions. The
highly homologous group I isoforms (NM23-H1-H4 or
NME1-4) all possess NDPK activity, whereas group II members
(NM23-H5-H9 or NME5-9 and RP2, retinitis pigmentosa 2) are
not onlymore divergent in sequence but alsomanifest little or no
NDPK activity [9, 10]. It is now accepted that in melanomas and
in epithelial tumors such as breast, liver, colon, and cervical
carcinomas, NM23-H1 expression shows an inverse correlation
with metastatic potential [11–20]. However, in hematological
malignancies, ovarian and prostate cancer for example, the con-
verse is observed, where an upregulated NM23-H1 level corre-
lates with poor prognosis [21–23]. Studies in neuroblastoma also
reported a positive correlation between NM23-H1 expression
and tumor progression [24, 25]. Moreover, in aggressive cases
a S120G missense mutation was identified, which seems to be
specific for this tumor type [24, 26]. It is important to note that
NM23-H1 as a representing MSG is very rarely mutated in dif-
ferent tumor types, unlike tumor suppressor genes.
Besides the S120G mutation in neuroblastoma only loss-of-
heterozygosity (LOH) was observed in colorectal carcinoma
cases [27]. Rather the loss of NM23-H1 is typical in invasive
tumors where its expression seems to be downregulated either
at the transcriptional, translational or the posttranslational level
by mechanisms suggested above [4–8]. A decrease in NM23-
H1 expression in clinical specimens was also observed during
the invasion process: at the invasive front of hepatocellular and
colon carcinoma NM23-H1 staining was strongly reduced,
whereas it remained intense in the central body of the primary
tumor. These data argue for a dual regulation of NM23-H1
during tumor development and progression: overexpression
of NM23-H1 can be detected in the primary tumor compared
to the adjacent non tumoral tissue during early steps of tumor-
igenesis, and later a downregulation of NM23-H1 expression
occurs during metastatic progression [28].
Importantly, NM23members are pleiotropic in a number of
ways relating to the controlling steps of the metastatic cascade.
This includes cell migration [29], growth and differentiation
[20, 30, 31], signal transduction, transcriptional regulation
[32, 33], and apoptosis [34]. In addition, other molecular ac-
tivities have been assigned to NM23/NDPKs, such as
histidine-dependent protein kinase (histidine phosphotransfer-
ase) activity [35–38], unusual nuclease activity [39, 40], and
lipid bilayer-binding [41]. Taken together, multiple functions
have been assigned to the NM23/NDPK protein family and
many interaction partners were identified by different in vitro
methods [29].Thus NM23 gene family display pleiotropic
functions and their effect on metastatic progression might be
contradictory inmany cancers. These contradictory datamight
be due to the presence of highly homologous NM23 isoforms
in cells, especially NM23-H1 and NM23-H2, which are most
often not discriminated by antibodies and probes [42].
Conflicting data can also be explained by different cellular
context, as NDPKs were proposed to act in opposing ways
depending on the cellular environment where cells attached to
a surface show behaviour that differs from cells in a growth
medium [43]. In addition, it is unclear how loss of function of
NDPKwill manifest when they bound to partner proteins such
as CFTR, whose mutation causes cystic fibrosis (CF). For
example, in CF the works of R. Muimo in Sheffield, UK
and others show that both NM23-H1 and NM23-H2 are pres-
ent in a much larger complex of proteins bound to different
domains of the CF gene product CFTR. These NM23 proteins
are dysfunctional when CFTR is mutated. It is also observed
that a six fold rise in cancer of the young exists in this disease.
In the latter case, CFTR acts as a signalling hub by approx-
imating many partners, akin to the role of NDPK in Ras sig-
nalling complexes [44]. Emerging data suggest that other sig-
nalling pathways implicated in cancer progression, for exam-
ple PI3K signalling may also have opposing outcomes in a
context-dependent manner [45]. Therefore, experiments car-
ried out in developmental models in vivo have been required
to unravel the biological functions of NM23/NDPK family
members (reviewed in [46]).
In this review we focus on two main issues: 1. we provide
an overview on results obtained from model organisms that
help to illuminate human NM23 data. 2. We emphasize three
processes making up part of the metastatic cascade, e.g. cell
migration and invasion, proliferation and apoptosis.
Studies on Model Organisms Contributed
to Reveal the Biological Functions
of NM23/NDPKs
Model organisms often serve as proxies for understanding
basic questions related to human diseases [47]. As NDPKs
are highly conserved from yeast to human [10, 48], and almost
identical around the catalytic site where the phosphorylated
histidine resides, we and others were able to leverage the few-
er number of isoforms found inmodel organisms. This paucity
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of NM23 genes in flies, worms and amoebae has significantly
contributed to the understanding of the biology in relation to
human data. In the fruit fly, a mutation named Killer of prune
(K-pn) causes no phenotype by itself but causes lethality in
individuals homozygous for the nonlethal mutation prune (pn)
which causes a prune (not red) color of the eye [49]. Thirty
years later, the laboratory of Allen Shearn presented evidence
that Killer of prune is a mutation in the abnormal wing discs
(awd) gene identified through studies on imaginal disc devel-
opment [50, 51]. Imaginal discs are sac-like epithelial struc-
tures that fail to form after awd deletion when Drosophila
larvae try to develop into adult structures such as legs, anten-
nae, wings, etc.
One year later, the Drosophila AWD was shown to be the
homolog of NM23 (78% amino acid identity) [52].
Independently, an NDPK was cloned from the social amoeba
Dictyostelium discoideum, and shown to be highly homolo-
gous to AWD and NM23 giving a function to these proteins
[53, 54]. Parallel experiments monitored the enzymatic ‘activ-
ities’ of NM23 and AWD proteins finding that awd loss-of-
function mutant larvae showed a strongly decreased NDPK
activity because AWD provides ~ 98% of NDPK activity in
Drosophila embryos [53]. The involvement of the NDPK ac-
tivity in the awd phenotype was demonstrated in vivo in the
fruit fly. This function is linked to a high energy N-phosphate
linkage on histidine119 (histidine118 residue in human
NM23) in the catalytic site [55]. Loss-of-function awd mu-
tants cannot be complemented by the transgene carrying the
H119A allele – which encodes a kinase dead enzyme -, only
the wild-type awd cDNA-containing construct could rescue
awd’s null mutation [55]. Additionally, the larval lethality
phenotype of awdmutants was completely rescued by human
NM23-H2, the most ancient NDPK, but not by its chromo-
somally adjacent human NM23-H1 that arose by later gene
duplication.
In the mouse, 8 NDPK paralogs have been identified,
which can be divided into two distinct groups similar to hu-
man: NM23-M1-M4 isoforms are group I NDPKs, group II
consists of M5-M8 isoforms [56]. NM23-M1 and NM23-M2
show 94% and 98% sequence identity with their human ho-
mologs, respectively.
To gain insight into NM23 proteins’ functions in a relative-
ly close and highly relevant model organism to human, con-
stitutive knockout mice have been generated for NM23-M1
[57], NM23-M2 [58], a double knockout of NM23-M1 and
NM23-M2 [59], and from the group II NM23-M5 and
NM23-M7 [60]. Single mutant mice for NM23-M1 or
NM23-M2 are viable and beside a few developmental defects
able to develop into adulthood. NM23-M1 knockout mice de-
velop a mild hypotrophy [57] and females display defective
mammary gland growth with poor mammary duct maturation
of the nipple [61]; as a result these females cannot feed their
pups. The lack of NM23-M2 affects the function of the
immune system. In NM23-M2 knockout mice T and B cell
development is normal, but the T helper (Th) 1 and 2 cell
types show insufficient cytokine production. In addition, in
these CD4+ T cells the presence of the functional NM23-M2
is crucial for the K+ channel KCa3.1 activation, which occurs
by phosphorylation through the histidine kinase activity of
NM23-M2 [62]. NM23-M1/NM23-M2 double knockout mice
die perinatally [59] and suffer in hematological defects such as
anemia with damaged maturation of erythrocytes, suggesting
that NM23-M1 andNM23-M2 functions are indispensable for
erythroid lineage development. It is likely that in double mu-
tant mice, the level of triphospho-nucleoside precursors is
insufficient for DNA and RNA synthesis. Genes from group
II were characterized as components of axonemal structures of
cilia and flagella [9]. Constitutive NM23-M5 and NM23-M7
knockout mice have already been generated [60, 63, 64], and
showed situs inversus and hydrocephalus, respectively, phe-
notypes due to impaired motility of cilia.
Conditional knockout mice do not exist yet for NDPKs, but
both conditional knockouts and specific tissue targeted dele-
tions of murine NDPKs would significantly contribute to un-
derstand NDPKs’ function in the future.
The Role of NM23-H1 in Processes Driving
Metastatic Progression
Cell Migration and Invasion
Primary tumor cells have to gain many capabilities in order to
execute the metastatic program. One of the first characteristics
needed is to acquire motility and invasion. Many biological
functions are associated with the NM23/NDPK protein fami-
ly, although not all of them are confirmed so far in in vivo
systems. However, the ability of NM23-H1 to suppress cell
migration and invasiveness is an accepted property [65].
Three types of evidence have been provided thus far to
demonstrate the anti-metastatic activity of NM23-H1 or its
mouse homolog NM23-M1. 1. Murine experiments by
Boissan et al [66] proved the anti-metastatic effect of
NM23-M1 as follows: crossing of transgenic mice prone to
hepatocellular carcinoma (ASV mice expressing the SV 40
large T antigen in the liver leading to hepatocellular carcino-
ma), into an NM23-M1 knockout strain, resulted in double
transgenic mice showing a higher incidence of lung metasta-
ses compared to the or iginal s ingle mutants . 2 .
Overexpression ofNM23-H1/M1 in human or mouse invasive
cell lines, where their endogenous expression in the parental
line is low, resulted in reduction of the metastatic potential.
For example, reduced migratory potential and decrease in in-
vasiveness were observed in breast, colon, oral and hepatocel-
lular carcinoma and different melanoma cell lines, when
transfected with NM23 transgenes [67–70]. 3. In a related
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manner, in response to silencing of NM23-H1 in non-invasive
cancer cell lines derived from hepatocellular carcinoma and
colon cancer (where the endogenous NM23-H1 level is high),
an invasive/metastatic phenotype was observed [28].
Intercellular adhesion was lost, cell motility and extracellular
matrix invasion through type I collagen and Matrigel were
increased, accompanied by upregulation of MT1-MMP
(membrane-associated matrix metalloproteinase 1) expres-
sion, increased Rac1 signalling and MAPK (mitogen-activat-
ed protein kinase)/SAPK (stress-activated protein kinases) in-
cluding ERK and JNK, and PI3K/Akt pathway activation
[28]. Silencing of NM23-H1 was associated with formation
of invadopodia, defined as actin-drivenmembrane protrusions
endowed with matrix proteolytic activity due to MT1-MMP,
the key invadopodial metalloproteinase. In agreement with
these data, invasion was inhibited by expression of a catalytic
domain deletion mutant of MT1-MMP in silenced cells.
Conversely, overexpression of the proteolytically active form
of MT1-MMP promoted invasion in control cells and led to
further increased invasion of silenced cells. Several mecha-
nisms could explain how NM23-H1 inhibits cell migration.
These data centre on the negative regulation of Rho-Rac sig-
nalling by NM23-H1. Rac1 is a pleiotropic regulator of cell
motility, and the above experiments suggest that Rac1 activity
is inhibited by NM23-H1. In line with these data, Tiam1, a
Rac1-specific nucleotide exchange factor was shown to be
negatively regulated by NM23-H1, resulting in attenuated
Rac1 activation [71]. NM23-H1 was also shown to bind to
Dbl-1, a specific exchange factor of a Rho-type GTPase,
Cdc42. Binding of NM23-H1 to Dbl-1 inactivated Cdc42
and hence inhibited cell migration [72]. Interestingly, reduced
transcription of EDG2 encoding a lysophosphatidic acid re-
ceptor can also lead to decreased cel l mot i l i ty.
Downregulation of EDG2 expression can be obtained by in-
creasing expression of NM23-H1 [73]. Recently, an inverse
correlation between EDG2 and NM23 expression was also
observed during myeloid differentiation [74].
Several other important mechanisms were proposed by
which NM23-H1 exerts its effect on cell migration. First,
NM23-H1 was shown to bind to gelsolin and inactivate its
actin-severing capacity in order to suppress tumor cell motility
and metastasis [75]. Second, the puzzling awd/prune interac-
tion known from the fruit fly (see above) was further investi-
gated in breast cancer and it was found that NM23-H1 directly
interacts with the phosphodiesterase h-Prune [76] resulting in
increased cell motility due to an inhibitory sequestrative inter-
action with NM23-H1. Themechanism causing increasedmo-
tility of breast cancer cells was also explored by the formation
of the NM23-H1/hPrune complex, which is induced through
phosphorylation of NM23-H1 by casein kinase I in specific
Ser residues [77]. In colon cancer cells NM23-H1 was found
to inhibit cell migration via phosphorylation of the myosin
light chain (MLC) [78]. TGF-β signalling is a major inducer
of epithelial-mesenchymal transition. TGF-β treatment of
lung cancer cells resulted in increased invasive and migratory
potential, which was further enhanced by NM23-H1 knock-
down, meaning that NM23-H1 emerges as a new upstream
factor acting against epithelial-mesenchymal transition [79].
Thus, it appears that multiple mechanisms induce a strong
invasive and motile phenotype in response to NM23-H1 si-
lencing, in agreement with the multifunctional properties of
this metastasis-suppressor protein. This points also to a role of
NM23-H1 as a major upstream regulator of the metastatic
signaling cascade.
ComplementaryDrosophila studies in the Hsu lab revealed
a new, distinct mechanism whereby AWD, the fly counterpart
of mammalian NM23-H1 regulates cell migration.
AWD was the first NDPK whose role was examined in
in vivo cell migration models: AWD’s function was investi-
gated in two well characterised migrating cell types during
Drosophila development: in migration of tracheal cells and
border cells. Fly tracheogenesis is a model of tubular morpho-
genesis [80, 81]. The process starts during early embryogen-
esis by emergence of tracheal placodes, an invagination of
specialized ectodermal cells, from which tracheal branches
later develop. Cell migration and fusion events will give rise
to the tracheal network as tracheal branches elongate, migrate
and fuse to form tracheal tubules (branching morphogenesis).
FGF (fibroblast growth factor) is the key diffusive chemotac-
tic signal, which drives tracheal cell migration: migrating tra-
cheal cells express fibroblast growth factor receptor (FGFR)
on their surface and follow FGF, the signal released by the
surrounding tissues [80]. AWD was found to negatively reg-
ulate tracheal migration with low AWD dosage correlating
with ectopic migration of tracheal cells. Hsu and colleagues
proposed that AWD acts as a negative regulator of cell motil-
ity through modulating FGFR levels on tracheal cell surfaces
by regulating endocytosis of FGFR [82].
A similar approach can use border cell migration during
Drosophila oogenesis [83]. The egg chamber, a structure in
the fly ovary producing a given egg, is composed of the oo-
cyte and surrounding nurse cells (the so-called germ cell com-
plex), itself surrounded by a somatic epithelium of follicle
cells. Border cells are a special group of 6–10 follicular cells
which delaminate from the somatic epithelium and migrate to
the anterior pole of the oocyte to form the micropyle (entry
point of sperms) [83]. Although AWD is expressed in the
follicular epithelium, its expression is downregulated in bor-
der cells, which permits their migration [84]. Conversely,
overexpression of AWD results in stalled migration of border
cells, suggesting that AWD dosage inhibits the motility of
these cells as well [84]. Ligands of PDGF (platelet derived
growth factor) receptor and JAK/STAT pathways are known
to provide chemotactic signals for border cells [85–87]. Once
again, AWD influences the level of VEGF (vascular epithelial
growth factor)/PDGF receptors and JAK/STAT homologs
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(called Pvr and Domeless, respectively) on the surface of bor-
der cells through regulating receptor endocytosis, as seen in
tracheogenesis [84].
Importantly AWD partners Shibire, the homolog of human
Dynamin in these functions. This idea sits well with indepen-
dent data where AWD was identified as an exclusive binding
partner of Shibire/Dynamin during studies on Dynamin’s
function in synaptic vesicle recycling [88].
The data suggest that Dynamin (an atypical large GTPase)
plays a key role in the initiating step of endocytosis: Dynamin
is essential for generation of endocytic vesicles as it accumu-
lates around the neck of the invaginated cell membrane by
forming a polymerized helix [89]. GTP hydrolysis by the
Dynamin polymer leads to neck constriction and subsequent
vesicle fission. This model is supported by data from
Drosophila researchers showing that AWD functions as an
exclusive GTP supplier towards Shibire/Dynamin [88]. The
mechanistic basis of the Dynamin/NDPK interaction was pro-
vided by studying NM23’ role in endocytosis of several re-
ceptors in human and monkey cell lines: NDPKs fuel
Dynamin locally by GTP to make it possible to work at high
thermodynamic efficiency [90]. More recently, this idea has
been expanded by the Steeg lab that reports that NM23-H1
interacts with Dynamin in MDA-MB-231 breast carcinoma
cells and the above mentioned NDPK contribute to suppres-
sion of tumor cell motility by promoting endocytosis of che-
motactic receptors by facilitating Dynamin oligomerization
and increasing its GTPase activity [91].
Together, Drosophila studies are consistent across model
systems of migration revealing that the Dynamin/NDPK com-
plex plays an essential role in suppression of cell motility by
downregulating chemotactic receptor levels through receptor
internalization on the surface of migrating cells, further con-
firmed in human studies.
NM23/NDPK’s Role in Proliferation: NM23-H1
Influences the Outcome of the Ras/MAPK Cascade
by Interacting with KSR and the Ratio of ERK/p38
Signal Activity
Receptor tyrosine kinase (RTK)/Ras/extracellular signal
regulated kinase (ERK) signalling functions in many im-
portant biological processes, for example in cell prolifer-
ation, differentiation, cell migration and survival
(reviewed in [92]). The RTK/Ras/ERK pathway contrib-
utes significantly to proliferation of tumor cellsas muta-
tions in pathway components often lead to tumorigenesis
[93]. Kinase suppressor of Ras proteins (KSRs) are scaf-
folds which promote the assembly of Raf/MEK/ERK
complexes [94–96] and enable phosphorylation of
MAPK cascade components. KSR1 can bind all the mem-
bers of the MAPK pathway: it binds constitutively to
MEK and approximates MEK upon Ras activation to the
plasma membrane adjacent to Raf, thereby facilitating sig-
nal transduction. KSR scaffolds can themselves be regu-
lated by phosphorylating critical Ser residues. For exam-
ple p-Ser392 promotes binding of KSR to 14-3-3 proteins,
which in turn results in cytoplasmic sequestration and
inactivation of the scaffold [97]. Conversely, Ser392 de-
phosphorylation results in KSR activation, allowing its
localization to the plasma membrane. The phosphatase
PP2A, and two kinases, Cdc25C-associated kinase 1 (C-
TAK1) and NM23-H1 were found to operate on Ser392
residue to regulate cellular localization and thus activation
of KSR [97, 98]. Phosphorylation of Ser392 by NM23-H1
occurs through its histidine kinase activity [37]. The effect
of NM23-H1 exerted on MAPK signalling was also ex-
amined in MDA-MB-435 breast carcinoma cells where
NM23-H1 overexpression leads to KSR phosphorylation
and decreased act ivated MAPK (pERK) levels .
Conversely, silencing of NM23-H1 in HepG2 cells leads
to hyperactivation of ERK [28]. These data imply that
NM23-H1 negatively regulates the outcome of Ras/
MAPK signalling.
The KSR/NDPK interaction was confirmed in vivo in the
tractable genetic modelCaenorhabditis elegans [99]. The func-
tion of the nematode group I NDPK homolog NDK-1 was
shown to alter the size and composition of the hermaphrodite
reproductive organ, the vulva [99]. Vulval development is a
complex, highly cell-ordered set of events involving a cascade
of interacting pathways that includes EGFR/Ras/MAPK path-
way, together with Notch, Wnt and the Synthetic Multivulva
(SynMuv)). Their coordinated actions are essential when vulval
precursor cells (VPCs), a subset of epidermal blast cells, devel-
op the competence to form the vulval tissue. The ligand EGF
(epidermal growth factor), which initiates differentiation, is
produced by a specific cell of the somatic gonad, the anchor
cell (AC). EGF activates the EGFR/Ras/MAPK pathway in the
three closest VPCs, P(5–7).p (reviewed in [100, 101]). These
induced VPCs each divide three times and give rise to the 22
daughter cells that will form the adult vulval structure fol-
lowing cell migration and fusion events. Different pheno-
typic alterations can occur due to defects in EGFR/Ras/
MAPK signalling: lack of Ras signal leads to the
Vulvaless phenotype (absence of vulva), whereas increased
Ras signalling causes aMultivulva phenotype (’excess’ vul-
va development, reviewed in [100]). ndk-1 null mutants
display a Protruding vulva (Pvl) phenotype, due to the ever-
sion of the vulval tissue [102]. Epistasis analysis was used
to position ndk-1 in the process of vulval patterning and
ndk-1 was found to act downstream of lin-45/Raf but up-
stream of mek-2/MEK and mpk-1/MAPK in the EGFR/Ras/
MAPK pathway [99]. In line with these data, a significant
decrease was detected in activated phospho-MAPK levels
in somatic tissues of ndk-1 knockouts, accompanied by un-
changed total MAPK levels. Moreover, activated MAPK
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was not detectable in the germline of mutants, suggesting
that Ras/MAPK signalling is inhibited in the absence of
NDK-1 [99].
In C. elegans, the scaffold proteins KSR-1/KSR-2 are gen-
erally indispensable for MAPK activation [103] and based on
the above data NDK-1 also contributes to full activation of
MAPK signalling. Hence, ndk-1(-);ksr-1(-) and ndk-1(-)ksr-
2(-) double knockouts were generated. Both double mutants
showed enhanced single mutant phenotypes, verifying the ge-
netic interactions between ndk-1 and ksr genes. NDK-1 also
showed a physical interaction with worm KSR-2 and murine
KSR-1 by in vitro pulldown experiments [99]. Thus, a previ-
ously proposed link [37, 104] was confirmed in vivo between
an NDPK and KSR scaffolds [99] but the effect differs be-
tween species. In human studies, NM23-H1 attenuates Ras/
MAPK signalling through phosphorylation of KSR [37, 104],
in contrast, worm NDK-1 promotes the Ras/MAPK pathway
as it is required for proper MAPK activation [99]. One hy-
pothesis for future study suggests that this discrepancy might
be due to a differential regulation of the KSR scaffold.
Activation of RTK/Ras/MAPK pathway as a main prolif-
eration signal plays an important role at a late step of the
metastatic cascade, when tumor cells leave the primary tumor,
arrive to a new environment through the circulation and form
a new tumor focus at the secondary site.
If disseminated tumor cells (also called micrometastases) are
able to adapt to the new challengingmicroenvironment, can start
to proliferate and form a secondary tumor focus. Successful
metastatic colonization with formation of macrometastases often
depends on employing proliferation signals and avoiding apo-
ptotic signals by the micrometastatic cells [105, 106].
Micrometastases can develop basically into three different direc-
tions: 1.Micrometastases undergo cell death if they are unable to
resist to apoptotic signals. 2. Metastatic dormancy frequently
occurs when micrometastatic dormant cells are able to survive
but do not proliferate. In this case apoptotic vs proliferative sig-
nals are balanced.Metastasis suppressor genes contribute tomet-
astatic dormancy by participating in the above processes [107].
3. Successful colonization to macrometastases happens if
micrometastatic cells avoid apoptosis and manage to proliferate
(Fig. 1). The ratio of ERK/p38 signal activity is known to con-
tribute to successful development of macrometastases from dis-
seminated tumor cells: high ERK/p38 activated ratio favours
tumor growth, whereas high p38/ERK activated ratio induces
tumor growth arrest (dormancy) in vivo [108]. The expression
ofEDG2 or LPA1 (lysophosphatidic acid receptor 1) gene shows
an inverse correlation with that ofNM23-H1. The effect of LPA1
inhibition (which is attached to NM23-H1 overexpression) was
examined in an experimental pulmonary metastasis mouse mod-
el, and it was found by Marshall et al. [109] that the LPA1
inhibitor Debio-0719 induced high p38/ERK activated ratio in
the lung, indicative of metastatic dormancy at the secondary site
(reviewed in [110]).
The Role of NM23/NDPKs in Apoptosis, Apoptotic
Engulfment and Phagocytosis
In recent decades of study on the sequential steps underpin-
ning the metastatic cascade, it has been established that type I
programmed cell death or apoptosis is a barrier that tumor
cells have to overcome in order to survive and proliferate
(reviewed in [111–113]). Based on this logic, NM23 acts
against tumor progression in two different ways: 1. in several
cell types it was shown to act in the dying cell to promote cell
death; 2. it functions in any engulfing cell with phagocytic
capacity. The purpose of the latter is to eliminate the debris
of the apoptotic cell in order to prevent inflammation, given
that inflammation is a factor that might favour tumor progres-
sion [111].
Both human and C. elegans studies suggest that NDPKs
play a role in several cases in the apoptotic cell. A recent study
inC. elegans showed that germ cell death in response to DNA
damage is mediated by NDK-1 through activation of the
MAPK cascade [114]. NDK-1 acts as an activator of the
MAPK pathway in somatic tissues of the worm; and this func-
tion of NDK-1 was confirmed from a different aspect, during
germ cell apoptosis [114]. DNA damage-induced apoptosis of
C. elegans germ cells is mostly driven by the MAPK pathway
[115, 116]. mir-35 miRNA has an important function in this
process, as absence of mir-35 leads to elevated levels of acti-
vated (phosphorylated) MAPK. The 3’-UTR of ndk-1 con-
tains a single mir-35 binding site, where mir-35 is able to
inhibit translation of ndk-1, thus MAPK pathway’s activation
is retained. In response to irradiation in the C. elegans
germline (applying genotoxic stress), elevated NDK-1::GFP
levels were experienced in germ cells destined to die; espe-
cially, if the mir-35 binding site was mutated in ndk-1’s 3’-
UTR, the refractile morphology of apoptotic germ cells sud-
denly occurred. The authors conclude that mir-35 acts as a
buffer to maintain the threshold of apoptosis, by influencing
MAPK activation through NDK-1 [114].
Earlier studies already linked NDPKs to another special-
ized type of cell death: human NM23-H1 acts in caspase-
independent apoptosis as a granzyme A-activated DNAse
(GAAD) [34, 117]. Similar to the earlier trends showed, those
granzyme A-treated cel ls in which NM23-H1 is
overexpressed, turned out to be more sensitive to granzyme
A-mediated DNA damage and cytolysis.
Another interesting set of data linked NM23-H1 to apopto-
sis found by Boissan et al: HepG2 cells treated by siRNA
specific for NM23-H1 showed reduced sensitivity to chemo-
therapeutic agent-induced apoptosis [28].
In multicellular organisms dying cells are removed by
neighbouring cells or specialized phagocytes, which engulf
the apoptotic cells and destroy their debris. The internalized
apoptotic cells are subsequently degraded inside phagosomes,
which undergo a multistep process called phagosome
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maturation that involves the fusion of phagosomes and multi-
ple kinds of intracellular organelles accompanied by the grad-
ual acidification of the phagosomal lumen [118]. The presence
of uncleared apoptotic cells has been associated with different
diseases that involve inflammation, autoimmunity and cancer
[119]. As a result of insufficient removal of apoptotic cells,
chronic inflammation occurs, which might favour tumor
growth and progression [120]. In context of apoptotic cell
clearance (2. point above) and phagocytosis, we investigated
NDPKs function in phagocytosis inC. elegans: in the absence
of NDK-1 accumulation of apoptotic cell corpses was ob-
served, both in embryos and in the gonad of mutant hermaph-
rodites [121]. NDK-1::GFP expression was detected in the
gonadal sheath cells, which are specialized engulfing cells of
dying germ cells. Importantly, a genetic interaction occurred
between ndk-1 and dyn-1 (dynamin), which was later
confirmed at the protein level with multiple IP experiments
and in situ with DPLA (duolink proximity ligation assay)
[122]. Furthermore, NDK-1 acts in the same time-window
as DYN-1 on phagosomal surfaces, during engulfment and
the early steps of phagosome maturation. This connection
turned out to be conserved; DPLA confirmed the co-
localisation of NM23-H1 and Dynamin-2 in human macro-
phages as well, and increased enrichment of the two proteins
was shown at the phagocytic cups. Depleting NM23-H1 in
macrophages led to decreased phagocytic capacity.
Similarly, murine BMDMs (bone marrow–derived macro-
phages), due to NM23-M1 silencing engulfed significantly
less apoptotic thymocytes [122].
Thus, NM23/NDPKs role in phagocytosis is evolutionary
conserved. NM23-H1, NM23-M1 and NDK-1 are all factors
promoting phagocytosis [122].
Fig. 1 The role of NM23-H1, NM23-M1, AWD and NDK-1 in processes
related to the metastatic cascade. Metastasis formation is a complex and
multistep process, as a tumor cell acquires invasive characteristics and
passes through the steps of the metastatic cascade. In case of carcinomas,
tumor cells of epithelial origin detach from the primary tumor, gaining
access to the surrounding stroma by breaching the basement membrane
(invasion), then they enter the microvasculature of the lymphatic or blood
system (intravasation). Next they survive in the circulation avoiding
immune surveillance and translocate to distant tissues. Following
extravasation tumor cells (micrometastases) have to survive in a new
microenvironment of the distant tissue. After cancer cells have spread
from the primary tumor to a secondary site, just a small number of
them can conform to this new environment and form micro- and
macrometastases. The majority of these tumor cells step into a dormant
state or forced into apoptotic cell death by the signals from the new
microenvironment. Successful metastatic colonization with formation of
macrometastases often depends on avoidance of apoptotic signals and
employing proliferation signals by the micrometastases. Subsequently
secondary colonies will be eventually able to establish new blood
supplies. If any of these steps fail to occur, metastases cannot develop.
In this review we emphasize three major processes in which NM23-H1
and its homologs, AWD (D. melanogaster), NDK-1 (C. elegans) and
NM23-M1 (M. musculus) have an important role. These processes are
linked to different steps of the metastatic cascade. NM23-H1, AWD, and
NDK-1 inhibit cell migration (NM23-H1 suppresses invasion as well).
NM23-H1 was shown to inhibit proliferation. NM23-H1, NM23-M1 and
NDK-1 promote phagocytosis, whereby apoptotic cell debris are
eliminated by macrophages. Cell migration plays a role in an early step
of the metastatic cascade, whereas proliferation and apoptosis are
processes influencing a late step, metastatic colonization.
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Conclusion
In this review we examined the role of NM23-H1 and its
homologs in three processes making part of the metastatic
cascade, e.g. cell migration and invasion, proliferation and
apoptosis.
Cell invasion and migration play an important early role in
the metastatic cascade: capability of invasion and migration
are among the first features primary tumor cells need to ac-
quire in order to evolve into metastases. Several pro-invasive
signalling pathways are inhibited by NM23-H1, including the
Rac1 pathway, MAPK/SAPK, PI3K/Akt. NM23-H1 inhibits
formation of invadopodia and thus proteolysis of extracellular
matrices through modulation of MT1-MMP expression.
NM23-H1 homologs are well known inhibitors of cell migra-
tion (Fig. 1). Human studies linked NM23-H1 to cell migra-
tion inhibition through modifying Rho-Rac and TGFβ signal-
ling and actin remodeling. Two in vivo cell migration models
served to examine the role of AWD, the fly counterpart of
NM23-H1, in regulating cell motility in Drosophila,
tracheogenesis and border cell migration. These studies re-
vealed that AWD is a negative regulator of cell motility
through modulating endocytosis of chemotactic receptors on
the surface of migrating cells in cooperation with Shibire/
Dynamin. Recent work by Patricia Steeg and colleagues
shows that NM23-H1 facilitated Dynamin activity, thereby
promoting endocytosis of chemotactic receptors and suppress-
ing tumor cell motility.
In the above fly and human studies endocytosis of the fol-
lowing receptors were examined: FGFR (tracheal migration),
VEGFR/PDGFR (border cell migration), EGFR (studies on
human cell lines). We note that all these receptors play a role
as deregulated factors involved and detected in many different
cancer types. Thus, they represent therapeutic targets in per-
sonalized medicine [123].
NM23-H1 might function in a late step of the metasta-
tic cascade as well by inducing tumor dormancy when
apoptotic and proliferative signals are balanced. NM23-
H1 inhibits tumor cell proliferation by phosphorylating
the MAPK scaffold KSR resulting in suppression of
MAPK signalling. Overexpression of NM23-H1 was
shown to promote metastatic dormancy in a pulmonary
metastasis mouse model. Although the exact mechanism
remains to elucidate, in this mouse model a high activated
Table 1 NM23-H1 and its M. musculus, D. melanogaster and C. elegans counterparts participate in three main processes linked to the metastatic
cascade
Organism Factor Regulated pathways Function and biological role Citation
Migration and
invasion
Human tumor (e.g. breast,
colon, oral, hepatocellular
carcinoma andmelanoma)
cell lines
NM23-H1 Rho - Rac1 signaling
MAPK/SAPK and
PI3K/Akt pathway
downregulation
Gelsolin
hPrune
EDG2
MLC
TGFβ
Inhibition of cell motility and
invasion
[67–70]
[71–73]
[28]
[75]
[76–77]
[73]
[78]
[79]
D. melanogaster AWD FGFR PDGFR/VEGFR Tracheogenesis and border
cell migration
[82]
[84]
M. musculus NM23-M1 Increased incidence of lung
metastases in NM23-M1
KO mice prone to develop
hepatocellular carcinoma
[66]
Proliferation Human breast carcinoma cell
line
NM23-H1 Suppression of Ras-MAPK
signalling through KSR
Proliferation [37]
[104]
C. elegans NDK-1 Activation of Ras-MAPK
signaling through KSR
Vulval development [99]
Apoptotic engulfment
and phagocytosis
Human macrophages
(primary cell culture)
NM23-H1 Phagocytosis of zymosan and
IgG-opsonized RBCs
[122]
M. musculus bone
marrow-derived
macrophages
NM23-M1 Engulfment of apoptotic
thymocytes
[122]
C. elegans NDK-1 Apoptotic clearance of
embryonic and germ cells
[121]
[122]
Three main processes (cell migration and invasion, proliferation, apoptotic engulfment/phagocytosis) linked to the metastatic cascade where NM23-H1
and its homologs in model organisms play an important role. Biological functions and the molecular background are also indicated if known. Related
citations are listed. See details in the text
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p38/ERK ratio was found meaning that proliferative ERK
signalling was indeed suppressed in response to NM23-H1
overexpression.
Both NM23-H1 and its C. elegans homolog NDK-1 were
found to promote apoptotic cell death of several cell types,
although this issue needs further investigation. In addition,
NM23-H1, its mouse and worm homologs function in
engulfing cells to eliminate debris of the apoptotic cells, as
they promote phagocytosis in an evolutionary conserved man-
ner. Apoptotic clearance is an important issue from cancer
perspective, as the accumulation of apoptotic cell corpses
can trigger inflammation, which creates a supporting environ-
ment for tumor progression [111, 124].
NM23-H1 and its homologs were shown to be involved in
the above processes (Fig. 1 and Table 1). Inhibition of cell
invasion/migration and proliferation, and helping apoptosis
and phagocytosis are all mechanisms, whereby NM23-H1
acts against metastatic progression.
Acknowledgements K.T.-V. was supported by the OTKA grant
K115587. Project no. FIEK_16-1-2016-0005 has been implemented with
the support provided from the National Research, Development and
Innovation Fund of Hungary, financed under the FIEK_16 funding
scheme.
A. S. was financed by the following grants: NKFI-FK-128404
National Research, Development and Innovation Office. Project no.
ED_17-1-2017-0009 from National Research, Development and
Innovation Fund of Hungary financed under the National Bionics
Program. DSc Degree Processing Support for Woman-Mother Scientists
of the Hungarian Academy of Sciences.
Funding Information Open access funding provided by Eötvös Loránd
University (ELTE).
Compliance with Ethical Standards
Conflict of Interest The authors declare no conflicts of interests.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing, adap-
tation, distribution and reproduction in any medium or format, as long as
you give appropriate credit to the original author(s) and the source, pro-
vide a link to the Creative Commons licence, and indicate if changes were
made. The images or other third party material in this article are included
in the article's Creative Commons licence, unless indicated otherwise in a
credit line to the material. If material is not included in the article's
Creative Commons licence and your intended use is not permitted by
statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this
licence, visit http://creativecommons.org/licenses/by/4.0/.
References
1. Stafford LJ, Vaidya KS, Welch DR (2008) Metastasis suppressors
genes in cancer. Int J Biochem Cell Biol 40:874–891. https://doi.
org/10.1016/j.biocel.2007.12.016
2. Khan I, Steeg PS (2018) Metastasis suppressors: functional path-
ways. Lab Invest 98:198–210. https://doi.org/10.1038/labinvest.
2017.104
3. Steeg PS, Bevilacqua G, Kopper L et al (1988) Evidence for a
novel gene associated with low tumor metastatic potential. J Natl
Cancer Inst 80:200–204. https://doi.org/10.1093/jnci/80.3.200
4. Fiore LS, Ganguly SS, Sledziona J et al (2014) c-Abl and Arg
induce cathepsin-mediated lysosomal degradation of the NM23-
H1 metastasis suppressor in invasive cancer. Oncogene 33:4508–
4520. https://doi.org/10.1038/onc.2013.399
5. Pal S, Vishwanath SN, Erdjument-Bromage H et al (2004) Human
SWI/SNF-associated PRMT5 methylates histone H3 arginine 8
and negatively regulates expression of ST7 and NM23 tumor sup-
pressor genes. Mol Cell Biol 24:9630–9645. https://doi.org/10.
1128/MCB.24.21.9630-9645.2004
6. Hartsough MT, Clare SE, Mair M et al (2001) Elevation of breast
carcinoma Nm23-H1 metastasis suppressor gene expression and
reduced motility by DNA methylation inhibition. Cancer Res 61:
2320–2327
7. Chen W, Xiong S, Li J et al (2015) The ubiquitin E3 ligase SCF-
FBXO24 recognizes deacetylated nucleoside diphosphate kinase
A to enhance its degradation. Mol Cell Biol 35:1001–1013.
https://doi.org/10.1128/MCB.01185-14
8. Almeida MI, Nicoloso MS, Zeng L et al (2012) Strand-specific miR-
28-5p and miR-28-3p have distinct effects in colorectal cancer cells.
Gastroenterology 142. https://doi.org/10.1053/j.gastro.2011.12.047
9. Boissan M, Dabernat S, Peuchant E et al (2009) The mammalian
Nm23/NDPK family: from metastasis control to cilia movement.
Mol Cell Biochem 329:51–62. https://doi.org/10.1007/s11010-
009-0120-7
10. Desvignes T, Pontarotti P, Fauvel C, Bobe J (2009) Nme protein
family evolutionary history, a vertebrate perspective. BMC Evol
Biol 9:256. https://doi.org/10.1186/1471-2148-9-256
11. Bevilacqua G, Sobel ME, Liotta LA, Steeg PS (1989) Association of
low nm23 RNA levels in human primary infiltrating ductal breast
carcinomaswith lymph node involvement and other histopathological
indicators of high metastatic potential. Cancer Res 49:5185–5190
12. Flørenes VA, Aamdal S, Myklebost O et al (1992) Levels of nm23
messenger RNA in metastatic malignant melanomas: inverse cor-
relation to disease progression. Cancer Res 52:6088–6091
13. Xerri L, Grob JJ, Battyani Z et al (1994) NM23 expression in
metastasis of malignant melanoma is a predictive prognostic pa-
rameter correlated with survival. Br J Cancer 70:1224–1228.
https://doi.org/10.1038/bjc.1994.477
14. Boissan M, Lacombe M-L (2006) Nm23/NDP kinases in hepato-
cellular carcinoma. J Bioenerg Biomembr 38:169–175. https://doi.
org/10.1007/s10863-006-9031-4
15. An R, Meng J, Shi Q et al (2010) Expressions of nucleoside
diphosphate kinase (nm23) in tumor tissues are related with me-
tastasis and length of survival of patients with hepatocellular car-
cinoma. Biomed Environ Sci 23:267–272. https://doi.org/10.
1016/S0895-3988(10)60062-1
16. Hartsough MT, Steeg PS (2000) Nm23/nucleoside diphosphate
kinase in human cancers. J Bioenerg Biomembr 32:301–308.
https://doi.org/10.1023/a:1005597231776
17. Lacombe M-L, Boissan M (2013) NME1 (NME/NM23 nucleo-
side diphosphate kinase 1). Atlas Genet Cytogenet Oncol
Haematol 17:526–538
18. Liu L, Li M, Zhang C et al (2018) Prognostic value and clinico-
pathologic significance of nm23 in various cancers: A systematic
review and meta-analysis. Int J Surg 60:257–265. https://doi.org/
10.1016/j.ijsu.2018.10.035
19. Leonard MK, McCorkle JR, Snyder DE et al (2018) Identification of
a gene expression signature associated with the metastasis suppressor
The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis 57
function of NME1: Prognostic value in human melanoma. Lab
Investig 98:327–338. https://doi.org/10.1038/labinvest.2017.108
20. Howlett AR, Petersen OW, Steeg PS, Bissell MJ (1994) A novel
function for the nm23-H1 gene: overexpression in human breast
carcinoma cells leads to the formation of basement membrane and
growth arrest. J Natl Cancer Inst 86:1838–1844. https://doi.org/10.
1093/jnci/86.24.1838
21. Harłozińska A, Bar JK, Gerber J (1996) nm23 expression in tissue
sections and tumor effusion cells of ovarian neoplasms. Int J
Cancer 69:415–9. https://doi.org/10.1002/(SICI)1097-
0215(19961021)69:5<415::AID-IJC11>3.0.CO;2-1
22. Niitsu N, Nakamine H, Okamoto M et al (2003) Expression of
nm23-H1 is associated with poor prognosis in peripheral T-cell
lymphoma. Br J Haematol 123:621–630. https://doi.org/10.1046/
j.1365-2141.2003.04668.x
23. Andolfo I, De Martino D, Liguori L et al (2011) Correlation of
NM23-H1 cytoplasmic expression with metastatic stage in human
prostate cancer tissue. Naunyn Schmiedebergs Arch Pharmacol
384:489–498. https://doi.org/10.1007/s00210-011-0645-7
24. Chang CL, Zhu XX, Thoraval DH et al (1994) Nm23-H1 muta-
tion in neuroblastoma. Nature 370:335–336. https://doi.org/10.
1038/370335a0
25. Garcia I, Mayol G, Rios J et al (2012) AThree-Gene Expression
Signature Model for Risk Stratification of Patients with
Neuroblastoma. Clin Cancer Res 18:2012–2023. https://doi.org/
10.1158/1078-0432.CCR-11-2483
26. Tan C-Y, Chang CL (2018) NDPKA is not just a metastasis sup-
pressor - be aware of its metastasis-promoting role in neuroblas-
toma. Lab Invest 98:219–227. https://doi.org/10.1038/labinvest.
2017.105
27. Kapitanović S, Čačev T, Berković M et al (2004) nm23-H1 ex-
pression and loss of heterozygosity in colon adenocarcinoma. J
Clin Pathol 57:1312–1318. https://doi.org/10.1136/jcp.2004.
017954
28. Boissan M, De Wever O, Lizarraga F et al (2010) Implication of
metastasis suppressor NM23-H1 in maintaining adherens junctions
and limiting the invasive potential of human cancer cells. Cancer
Res 70:7710–7722. https://doi.org/10.1158/0008-5472.CAN-10-
1887
29. Marino N, Marshall J-C, Steeg PS (2011) Protein-protein interac-
tions: a mechanism regulating the anti-metastatic properties of
Nm23-H1. Naunyn Schmiedebergs Arch Pharmacol 384:351–
362. https://doi.org/10.1007/s00210-011-0646-6
30. LeeM-Y, JeongW-J, Oh J-W, Choi K-Y (2009) NM23H2 inhibits
EGF- and Ras-induced proliferation of NIH3T3 cells by blocking
the ERK pathway. Cancer Lett 275:221–226. https://doi.org/10.
1016/j.canlet.2008.10.018
31. Mochizuki T, Bilitou A, Waters CT et al (2009) Xenopus NM23-
X4 regulates retinal gliogenesis through interaction with p27Xic1.
Neural Dev 4:1. https://doi.org/10.1186/1749-8104-4-1
32. Postel EH, Berberich SJ, Flint SJ, Ferrone CA (1993) Human c-
myc transcription factor PuF identified as nm23-H2 nucleoside
diphosphate kinase, a candidate suppressor of tumor metastasis.
Science 261:478–480. https://doi.org/10.1126/science.8392752
33. Thakur RK, Kumar P, Halder K et al (2009)Metastases suppressor
NM23-H2 interaction with G-quadruplex DNA within c-MYC
promoter nuclease hypersensitive element induces c-MYC expres-
sion. Nucleic Acids Res 37:172–183. https://doi.org/10.1093/nar/
gkn919
34. Fan Z, Beresford PJ, Oh DY et al (2003) Tumor suppressor
NM23-H1 is a granzyme A-activated DNase during CTL-
mediated apoptosis, and the nucleosome assembly protein SET
is its inhibitor. Cell 112:659–672. https://doi.org/10.1016/s0092-
8674(03)00150-8
35. Klumpp S, Krieglstein J (2009) Reversible phosphorylation of
histidine residues in proteins from vertebrates. Sci Signal 2:pe13.
https://doi.org/10.1126/scisignal.261pe13
36. Khan I, Steeg PS (2018) The relationship of NM23 (NME) me-
tastasis suppressor histidine phosphorylation to its nucleoside di-
phosphate kinase, histidine protein kinase and motility suppres-
sion activities. Oncotarget 9:10185–10202. https://doi.org/10.
18632/oncotarget.23796
37. Hartsough MT, Morrison DK, Salerno M et al (2002) Nm23-H1
Metastasis Suppressor Phosphorylation of Kinase Suppressor of
Ras via a Histidine Protein Kinase Pathway. J Biol Chem 277:
32389–32399. https://doi.org/10.1074/jbc.M203115200
38. Adam K, Hunter T (2018) Histidine kinases and the missing
phosphoproteome from prokaryotes to eukaryotes. Lab Invest
98:233–247. https://doi.org/10.1038/labinvest.2017.118
39. Ma D, Xing Z, Liu B et al (2002) NM23-H1 and NM23-H2
repress transcriptional activities of nuclease-hypersensitive ele-
ments in the platelet-derived growth factor-A promoter. J Biol
Chem 277:1560–1567. https://doi.org/10.1074/jbc.M108359200
40. ZhangQ,McCorkle JR, NovakM et al (2011)Metastasis suppres-
sor function of NM23-H1 requires its 3’-5’ exonuclease activity.
Int J cancer 128:40–50. https://doi.org/10.1002/ijc.25307
41. Tokarska-Schlattner M, Boissan M, Munier A et al (2008) The
nucleoside diphosphate kinase D (NM23-H4) binds the inner mi-
tochondrial membrane with high affinity to cardiolipin and cou-
ples nucleotide transfer with respiration. J Biol Chem 283:26198–
26207. https://doi.org/10.1074/jbc.M803132200
42. Boissan M, Schlattner U, Lacombe ML (2018) The NDPK/NME
superfamily: State of the art. Lab Investig 98:164–174
43. Annesley SJ, Bago R, Bosnar MH et al (2011) Dictyostelium
discoideum nucleoside diphosphate kinase C plays a negative reg-
ulatory role in phagocytosis, macropinocytosis and exocytosis.
PLoS One 6:e26024. https://doi.org/10.1371/journal.pone.
0026024
44. Kunzelmann K, Mehta A (2013) CFTR: a hub for kinases and
crosstalk of cAMP and Ca2+. FEBS J 280:4417–4429. https://
doi.org/10.1111/febs.12457
45. Madsen RR, Vanhaesebroeck B (2020) Cracking the context-
specific PI3K signaling code. Sci Signal 13. https://doi.org/10.
1126/scisignal.aay2940
46. Takács-Vellai K, Vellai T, Farkas Z, Mehta A (2015) Nucleoside
diphosphate kinases (NDPKs) in animal development. Cell Mol
Life Sci 72:1447–1462. https://doi.org/10.1007/s00018-014-1803-0
47. Hunter P (2008) The paradox of model organisms. The use of model
organisms in research will continue despite their shortcomings.
EMBO Rep 9:717–720. https://doi.org/10.1038/embor.2008.142
48. Bilitou A, Watson J, Gartner A, Ohnuma S (2009) The NM23
family in development. Mol Cell Biochem 329:17–33. https://
doi.org/10.1007/s11010-009-0121-6
49. Sturtevant AH (1956) A Highly Specific Complementary Lethal
System in Drosophila Melanogaster. Genetics 41:118–123
50. Biggs J, Tripoulas N, Hersperger E et al (1988) Analysis of the
lethal interaction between the prune and Killer of prune mutations
of Drosophila. Genes Dev 2:1333–1343. https://doi.org/10.1101/
gad.2.10.1333
51. Dearolf CR, Hersperger E, Shearn A (1988) Developmental con-
sequences of awdb3, a cell-autonomous lethal mutation of
Drosophila induced by hybrid dysgenesis. Dev Biol 129:159–
168. https://doi.org/10.1016/0012-1606(88)90170-4
52. Rosengard AM, Krutzsch HC, Shearn A et al (1989) Reduced
Nm23/Awd protein in tumour metastasis and aberrant
58 B. Mátyási et al.
Drosophila development. Nature 342:177–180. https://doi.org/10.
1038/342177a0
53. Biggs J, Hersperger E, Steeg PS et al (1990) A Drosophila gene
that is homologous to a mammalian gene associated with tumor
metastasis codes for a nucleoside diphosphate kinase. Cell 63:
933–940. https://doi.org/10.1016/0092-8674(90)90496-2
54. Wallet V, Mutzel R, Troll H et al (1990) Dictyostelium nucleoside
diphosphate kinase highly homologous to Nm23 and Awd pro-
teins involved in mammalian tumor metastasis and Drosophila
development. J Natl Cancer Inst 82:1199–1202. https://doi.org/
10.1093/jnci/82.14.1199
55. Xu J, Liu LZ, Deng XF et al (1996) The enzymatic activity of
Drosophila AWD/NDP kinase is necessary but not sufficient for
its biological function. Dev Biol 177:544–557. https://doi.org/10.
1006/dbio.1996.0184
56. Massé K, Dabernat S, Bourbon P-M et al (2002) Characterization
of the nm23-M2, nm23-M3 and nm23-M4 mouse genes: compar-
ison with their human orthologs. Gene 296:87–97. https://doi.org/
10.1016/s0378-1119(02)00836-3
57. Arnaud-Dabernat S, Bourbon PM, Dierich A et al (2003)
Knockout mice as model systems for studying nm23/NDP kinase
gene functions. Application to the nm23-M1 gene. J Bioenerg
Biomembr 35:19–30. https://doi.org/10.1023/a:1023561821551
58. Di L, Srivastava S, Zhdanova O et al (2010) Nucleoside diphos-
phate kinase B knock-out mice have impaired activation of the K +
channel KCa3.1, resulting in defective T cell activation. J Biol
Chem 285:38765–38771. https://doi.org/10.1074/jbc.M110.
168070
59. Postel EH, Wohlman I, Zou X et al (2009) Targeted deletion of
Nm23/nucleoside diphosphate kinase A and B reveals their re-
quirement for definitive erythropoiesis in the mouse embryo.
Dev Dyn 238:775–787. https://doi.org/10.1002/dvdy.21887
60. Vogel P, Read R, Hansen GM et al (2010) Situs inversus in
Dpcd/Poll-/-, Nme7-/-, and Pkd1l1-/- mice. Vet Pathol 47:120–
131. https://doi.org/10.1177/0300985809353553
61. Deplagne C, Peuchant E, Moranvillier I et al (2011) The anti-
metastatic nm23-1 gene is needed for the final step of mammary
duct maturation of the mouse nipple. PLoS One 6:e18645. https://
doi.org/10.1371/journal.pone.0018645
62. Srivastava S, Li Z, Ko K et al (2006) Histidine phosphorylation of
the potassium channel KCa3.1 by nucleoside diphosphate kinase
B is required for activation of KCa3.1 and CD4 T cells. Mol Cell
24:665–675. https://doi.org/10.1016/j.molcel.2006.11.012
63. Vogel P, Hansen G, Fontenot G, Read R (2010) Tubulin tyrosine
ligase-like 1 deficiency results in chronic rhinosinusitis and abnor-
mal development of spermatid flagella in mice. Vet Pathol 47:
703–712. https://doi.org/10.1177/0300985810363485
64. Vogel P, Read RW, Hansen GM et al (2012) Congenital hydro-
cephalus in genetically engineered mice. Vet Pathol 49:166–181.
https://doi.org/10.1177/0300985811415708
65. Farkas Z, Fancsalszky L, Saskoi É et al (2018) The dosage-
dependent effect exerted by the NM23-H1/H2 homolog NDK-1
on distal tip cell migration in C. elegans. Lab Investig 98:182–
189. https://doi.org/10.1038/labinvest.2017.99
66. BoissanM,WendumD,Arnaud-Dabernat S et al (2005) Increased
lung metastasis in transgenic NM23-Null/SV40 mice with hepa-
tocellular carcinoma. J Natl Cancer Inst 97:836–845. https://doi.
org/10.1093/jnci/dji143
67. Liu F, Zhang Y, Zhang X-Y, Chen H-L (2002) Transfection of the
nm23-H1 gene into human hepatocarcinoma cell line inhibits the
expression of sialyl Lewis X, alpha1,3 fucosyltransferase VII, and
metastatic potential. J Cancer Res Clin Oncol 128:189–196.
https://doi.org/10.1007/s00432-001-0314-1
68. Baba H, Urano T, Okada K et al (1995) Two isotypes of murine
nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2,
are involved in metastatic suppression of a murine melanoma line.
Cancer Res 55:1977–1981
69. Parhar RS, Shi Y, ZouM et al (1995) Effects of cytokine-mediated
modulation of nm23 expression on the invasion and metastatic
behavior of B16F10 melanoma cells. Int J cancer 60:204–210.
https://doi.org/10.1002/ijc.2910600213
70. Leone A, Flatow U, VanHoutte K, Steeg PS (1993) Transfection
of human nm23-H1 into the human MDA-MB-435 breast carci-
noma cell line: effects on tumor metastatic potential, colonization
and enzymatic activity. Oncogene 8:2325–2333
71. Otsuki Y, Tanaka M, Yoshii S et al (2001) Tumor metastasis sup-
pressor nm23H1 regulates Rac1 GTPase by interaction with
Tiam1. Proc Natl Acad Sci U S A 98:4385–4390. https://doi.org/
10.1073/pnas.071411598
72. Murakami M, Meneses PI, Knight JS et al (2008) Nm23-H1mod-
ulates the activity of the guanine exchange factor Dbl-1. Int J
cancer 123:500–510. https://doi.org/10.1002/ijc.23568
73. Horak CE, Lee JH, Elkahloun AG et al (2007) Nm23-H1 sup-
presses tumor cell moti l i ty by down-regulating the
lysophosphatidic acid receptor EDG2. Cancer Res 67:7238–
7246. https://doi.org/10.1158/0008-5472.CAN-07-0962
74. Okabe-Kado J, Hagiwara-Watanabe Y, Niitsu N et al (2018)
NM23 downregulation and lysophosphatidic acid receptor
EDG2/lpa1 upregulation during myeloid differentiation of human
leukemia cells. Leuk Res 66:39–48. https://doi.org/10.1016/j.
leukres.2018.01.003
75. Marino N, Marshall J-C, Collins JWet al (2013) Nm23-H1 Binds
to Gelsolin and Inactivates Its Actin-Severing Capacity to Promote
Tumor Cell Motility and Metastasis. Cancer Res 73:5949–5962.
https://doi.org/10.1158/0008-5472.CAN-13-0368
76. D’Angelo A, Garzia L, André A et al (2004) Prune cAMP phos-
phodiesterase binds nm23-H1 and promotes cancer metastasis.
Cancer Cell 5:137–149. https://doi.org/10.1016/s1535-6108(04)
00021-2
77. Garzia L, D’Angelo A, Amoresano A et al (2008)
Phosphorylation of nm23-H1 by CKI induces its complex forma-
tion with h-prune and promotes cell motility. Oncogene 27:1853–
1864. https://doi.org/10.1038/sj.onc.1210822
78. Suzuki E, Ota T, Tsukuda K et al (2004) nm23-H1 reduces in vitro
cell migration and the liver metastatic potential of colon cancer
cells by regulating myosin light chain phosphorylation. Int J can-
cer 108:207–211. https://doi.org/10.1002/ijc.11546
79. Zhao R, Gong L, Li L et al (2013) Nm23-H1 is a negative regu-
lator of TGF-Β1-dependent induction of epithelial-mesenchymal
transition. Exp Cell Res 319:740–749. https://doi.org/10.1016/j.
yexcr.2012.10.013
80. Affolter M, Caussinus E, Emoto H et al (2008) Tracheal branching
morphogenesis in Drosophila: new insights into cell behaviour
and organ architecture. Development 135:2055–2064. https://
doi.org/10.1242/dev.014498
81. Schottenfeld J, Song Y, Ghabrial AS (2010) Tube continued: mor-
phogenesis of the Drosophila tracheal system. Curr Opin Cell Biol
22:633–639. https://doi.org/10.1016/j.ceb.2010.07.016
82. Dammai V, Adryan B, Lavenburg KR, Hsu T (2003) Drosophila
awd, the homolog of human nm23, regulates FGF receptor levels
and functions synergistically with shi/dynamin during tracheal
development. Genes Dev 17:2812–2824. https://doi.org/10.1101/
gad.1096903
83. Montell DJ, Yoon WH, Starz-Gaiano M (2012) Group choreogra-
phy: mechanisms orchestrating the collective movement of border
The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis 59
cells. Nat Rev Mol Cell Biol 13:631–645. https://doi.org/10.1038/
nrm3433
84. Nallamothu G,Woolworth JA, Dammai V, Hsu T (2008) Awd, the
homolog of metastasis suppressor gene Nm23, regulates
Drosophila epithelial cell invasion. Mol Cell Biol 28:1964–
1973. https://doi.org/10.1128/MCB.01743-07
85. Duchek P, Somogyi K, Jékely G et al (2001) Guidance of cell
migration by the Drosophila PDGF/VEGF receptor. Cell 107:
17–26. https://doi.org/10.1016/s0092-8674(01)00502-5
86. McDonald JA, Pinheiro EM, Montell DJ (2003) PVF1, a
PDGF/VEGF homolog, is sufficient to guide border cells and
interacts genetically with Taiman. Development 130:3469–3478.
https://doi.org/10.1242/dev.00574
87. Silver DL, Geisbrecht ER, Montell DJ (2005) Requirement for
JAK/STAT signaling throughout border cell migration in
Drosophila. Development 132:3483–3492. https://doi.org/10.
1242/dev.01910
88. KrishnanKS, Rikhy R, Rao S et al (2001) Nucleoside diphosphate
kinase, a source of GTP, is required for dynamin-dependent syn-
aptic vesicle recycling. Neuron 30:197–210. https://doi.org/10.
1016/s0896-6273(01)00273-2
89. Ferguson SM, De Camilli P (2012) Dynamin, a membrane-
remodelling GTPase. Nat Rev Mol Cell Biol 13:75–88. https://
doi.org/10.1038/nrm3266
90. Boissan M, Montagnac G, Shen Q et al (2014) Membrane traf-
ficking. Nucleoside diphosphate kinases fuel dynamin superfam-
ily proteins with GTP for membrane remodeling. Science 344:
1510–1515. https://doi.org/10.1126/science.1253768
91. Khan I, Gril B, Steeg PS (2019) Metastasis Suppressors NME1
and NME2 Promote Dynamin 2 Oligomerization and Regulate
Tumor Cell Endocytosis, Motility and Metastasis. Cancer Res
canres.0492.2019. https://doi.org/10.1158/0008-5472.CAN-19-
0492
92. McKayMM, Morrison DK (2007) Integrating signals from RTKs
to ERK/MAPK. Oncogene 26:3113–3121. https://doi.org/10.
1038/sj.onc.1210394
93. Karnoub AE, Weinberg R (2008) Ras oncogenes: split personali-
ties. Nat Rev Mol Cell Biol 9:517–531. https://doi.org/10.1038/
nrm2438
94. Morrison DK (2001) KSR: a MAPK scaffold of the Ras pathway?
J Cell Sci 114:1609–1612
95. Roy F, Laberge G, Douziech M et al (2002) KSR is a scaffold
required for activation of the ERK/MAPKmodule. Genes Dev 16:
427–438. https://doi.org/10.1101/gad.962902
96. Alexa A, Varga J, Reményi A (2010) Scaffolds are “active” regu-
lators of signaling modules. FEBS J 277:4376–4382. https://doi.
org/10.1111/j.1742-4658.2010.07867.x
97. Müller J, Ory S, Copeland T et al (2001) C-TAK1 regulates Ras
signaling by phosphorylating the MAPK scaffold, KSR1. Mol
Cell 8:983–993. https://doi.org/10.1016/s1097-2765(01)00383-5
98. Ory S, Zhou M, Conrads TP et al (2003) Protein phosphatase 2A
positively regulates Ras signaling by dephosphorylating KSR1
and Raf-1 on critical 14-3-3 binding sites. Curr Biol 13:1356–
1364. https://doi.org/10.1016/s0960-9822(03)00535-9
99. Masoudi N, Fancsalszky L, Pourkarimi E et al (2013) The NM23-
H1/H2 homolog NDK-1 is required for full activation of Ras
signaling in C. elegans. Development 140:3486–3495. https://
doi.org/10.1242/dev.094011
100. Sundaram MV (2013) Canonical RTK-Ras-ERK signaling and
related alternative pathways. WormBook 1–38. https://doi.org/
10.1895/wormbook.1.80.2
101. Sternberg PW (2005) Vulval development. WormBook 1–28.
https://doi.org/10.1895/wormbook.1.6.1
102. Eisenmann DM, Kim SK (2000) Protruding vulva mutants iden-
tify novel loci and Wnt signaling factors that function during
Caenorhabditis elegans vulva development. Genetics 156:1097–
1116
103. Ohmachi M, Rocheleau CE, Church D et al (2002) C. elegans ksr-
1 and ksr-2 have both unique and redundant functions and are
required for MPK-1 ERK phosphorylation. Curr Biol 12:427–
433. https://doi.org/10.1016/s0960-9822(02)00690-5
104. Salerno M, Palmieri D, Bouadis A et al (2005) Nm23-H1 metas-
tasis suppressor expression level influences the binding properties,
stability, and function of the kinase suppressor of Ras1 (KSR1)
Erk scaffold in breast carcinoma cells. Mol Cell Biol 25:1379–
1388. https://doi.org/10.1128/MCB.25.4.1379-1388.2005
105. Aguirre-Ghiso JA (2007) Models, mechanisms and clinical evi-
dence for cancer dormancy. Nat Rev Cancer 7:834–846. https://
doi.org/10.1038/nrc2256
106. Holmgren L, O’reilly MS, Folkman J (1995) Dormancy of
micrometastases: Balanced proliferation and apoptosis in the pres-
ence of angiogenesis suppression. Nat Med 1:149–153. https://
doi.org/10.1038/nm0295-149
107. Horak CE, Lee JH, Marshall JC et al (2008) The role of metastasis
suppressor genes in metastatic dormancy. Apmis 116:586–601.
https://doi.org/10.1111/j.1600-0463.2008.01213.x
108. Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L (2003)
ERKMAPK activity as a determinant of tumor growth and dor-
mancy; regulation by p38SAPK. Cancer Res 63:1684–1695.
https://doi.org/10.1016/j.urolonc.2003.12.012
109. Marshall J-CA, Collins JW, Nakayama J et al (2012) Effect of
inhibition of the lysophosphatidic acid receptor 1 on metastasis
and metastatic dormancy in breast cancer. J Natl Cancer Inst
104:1306–1319. https://doi.org/10.1093/jnci/djs319
110. Marino N, Nakayama J, Collins JW, Steeg PS (2012) Insights into
the biology and prevention of tumor metastasis provided by the
Nm23 metastasis suppressor gene. Cancer Metastasis Rev 31:
593–603. https://doi.org/10.1007/s10555-012-9374-8
111. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next gen-
eration. Cell 144:646–674. https://doi.org/10.1016/j.cell.2011.02.013
112. Adams JM, Cory S (2007) The Bcl-2 apoptotic switch in cancer
development and therapy. Oncogene 26:1324–1337. https://doi.
org/10.1038/sj.onc.1210220
113. Lowe SW, Cepero E, Evan G (2004) Intrinsic tumour suppression.
Nature 432:307–315. https://doi.org/10.1038/nature03098
114. Tran AT, Chapman EM, FlamandMN et al (2019)MiR-35 buffers
apoptosis thresholds in the C. elegans germline by antagonizing
both MAPK and core apoptosis pathways. Cell Death Differ.
https://doi.org/10.1038/s41418-019-0325-6
115. Rutkowski R, Dickinson R, Stewart G et al (2011) Regulation of
Caenorhabditis elegans p53/CEP-1-dependent germ cell apoptosis
by Ras/MAPK signaling. PLoSGenet 7:e1002238. https://doi.org/
10.1371/journal.pgen.1002238
116. Perrin AJ, GundaM, Yu B et al (2013) Noncanonical control of C.
elegans germline apoptosis by the insulin/IGF-1 and Ras/MAPK
signaling pathways. Cell Death Differ 20:97–107. https://doi.org/
10.1038/cdd.2012.101
117. Chowdhury D, Beresford PJ, Zhu P et al (2006) The Exonuclease
TREX1 Is in the SET Complex and Acts in Concert with NM23-H1
to DegradeDNA duringGranzymeA-Mediated Cell Death.Mol Cell
23:133–142. https://doi.org/10.1016/j.molcel.2006.06.005
118. Lu N, Zhou Z (2012) Membrane trafficking and phagosome mat-
uration during the clearance of apoptotic cells. Int Rev Cell Mol
Biol 293:269–309. https://doi.org/10.1016/B978-0-12-394304-0.
00013-0
60 B. Mátyási et al.
119. Poon IKH, Lucas CD, Rossi AG, Ravichandran KS (2014)
Apoptotic cell clearance: basic biology and therapeutic potential.
Nat Rev Immunol 14:166–180. https://doi.org/10.1038/nri3607
120. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature
420:860–867. https://doi.org/10.1038/nature01322.Inflammation
121. Fancsalszky L, Monostori E, Farkas Z et al (2014) NDK-1, the
homolog of NM23-H1/H2 regulates cell migration and apoptotic
engulfment in C. elegans. PLoS One 9:e92687. https://doi.org/10.
1371/journal.pone.0092687
122. Farkas Z, Petric M, Liu X et al (2019) The nucleoside diphosphate
kinase NDK-1/NME1 promotes phagocytosis in concert with
DYN-1/Dynamin. FASEB J fj201900220R. https://doi.org/10.
1096/fj.201900220R
123. De Palma M, Hanahan D (2012) The biology of personalized
cancer medicine: facing individual complexities underlying hall-
mark capabilities. Mol Oncol 6:111–127. https://doi.org/10.1016/
j.molonc.2012.01.011
124. Martinez J, Almendinger J, Oberst A et al (2011) Microtubule-
associated protein 1 light chain 3 alpha (LC3)-associated phago-
cytosis is required for the efficient clearance of dead cells. Proc
Natl Acad Sci U S A 108:17396–17401. https://doi.org/10.1073/
pnas.1113421108
Publisher’s Note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis 61
